Patient Care

The provision of patient-centered stationary, semi-residential and outpatient care to mentally ill people of all stages of life is part of the tasks of the Central Institute of Mental Health.

The four clinics of CIMH provide advanced treatment in their respective area of specialization based on international standards.


As center of modern psychiatry renowned worldwide, CIMH realizes outstanding scientific results in cooperation with national and international organizations – right in the heart of Mannheim, the square city.

CIMH performs research regarding the development, progression and treatment of mental illnesses – from depression, ADHS, addiction diseases to schizophrenia, dementia or phobias.


CIMH acts as university hospital in its fields for the Medical Faculty Mannheim of Heidelberg University. It provides teaching and research in the areas of psychiatry, child and adolescent psychiatry, psychosomatic medicine and addiction research.

In addition, teaching is offered to students of statistics, bio sciences, jurisprudence, psychology and pharmacology.


The Central Institute of Mental Health in Mannheim was founded on April 8, 1975 as foundation of the state Baden-Württemberg together with Volkswagen Foundation. Its structure realizes a highly efficient model integration of patient-centered care, research and teaching.


As a psychiatric special hospital, the Central Institute of Mental Health offers diverse career options in patient-centered care.

As internationally renowned research institute and part of the Medical Faculty Mannheim of Heidelberg University, posts in research and teaching are available.

Das ZI ist am 26. Februar, von 6:00 bis 7:00 Uhr (a.m.), telefonisch nicht erreichbar!

In dieser Zeit wird unsere Telefonanlage neu gestartet. Die Mitarbeiterinnen und Mitarbeiter des ZI können aber per E-Mail erreicht werden - die Zentrale unter empfang Vielen Dank für Ihr Verständnis!


  • Zolfaghari S, Harenberg J, Frölich L, Weiss C, Wehling M, Wild P, Prochaska J, Beyer-Westendorf J, Koscielny J, Lip GY. Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference. Semin Thromb Hemost. 2015 Feb 19. [Epub ahead of print]
  • Ferentinos P, Koukounari A, Power R, Rivera M, Uher R, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Ising M, Maier W, Mors O, Rietschel M, Preisig M, Binder EB, Aitchison KJ, Mendlewicz J, Souery D, Hauser J, Henigsberg N, Breen G, Craig IW, Farmer AE, Müller-Myhsok B, McGuffin P, Lewis CM. Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. Psychol Med. 2015 Feb 20. [Epub ahead of print] :1-11.
  • Kiefer F, Kirsch M, Bach P, Hoffmann S, Reinhard I, Jorde A, von der Goltz C, Spanagel R, Mann K, Loeber S, Vollstädt-Klein S. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial. Psychopharmacology (Berl). 2015 Feb 21. [Epub ahead of print]
alle Publikationen